Eesti - eesti - Ravimiamet

intervet international b.v. - lawsonia intracellularis, inaktiveeritud - süsteemulsiooni lüofilisaat ja lahusti - 1annus 2ml 200ml 1tk; 1annus 2ml 100ml 1tk

Eesti - eesti - Ravimiamet

intervet international b.v. - lawsonia intracellularis, inaktiveeritud - süsteemulsiooni lüofilisaat ja lahusti - 1annus 0.2ml 50annus 10tk; 1annus 0.2ml 100annus 1tk; 1annus 0.2ml 50annus 1tk; 1annus 0.2ml 100annus 10tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

taw pharma (ireland) limited - klopidogreelvesinikkloriid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombootilised ained - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - indapamiid - toimeainet prolongeeritult vabastav tablett - 1,5mg 90tk; 1,5mg 20tk; 1,5mg 60tk; 1,5mg 30tk

Eesti - eesti - Ravimiamet

boehringer ingelheim vetmedica gmbh - lawsonia intracellularis, elus - suukaudse suspensiooni lüofilisaat ja lahusti - 1annus 50annus 1tk; 1annus 100annus 1tk; 1annus 10annus 1tk

Eesti - eesti - Ravimiamet

reckitt benckiser (poland) s.a. - ibuprofeen - suukaudne suspensioon - 40mg 1ml 30ml 1tk; 40mg 1ml 100ml 1tk; 40mg 1ml 200ml 1tk; 40mg 1ml 150ml 1tk; 40mg 1ml 50ml 1tk

Eesti - eesti - Ravimiamet

krka d.d. novo mesto - tsetüülpüridiinkloriid+bensokaiin - loseng - 1mg+5mg 18tk

Eesti - eesti - Ravimiamet

ideal trade links uab - ibuprofeen - suukaudne suspensioon - 40mg 1ml 100ml 1tk

Eesti - eesti - Ravimiamet

orifarm healthcare a/s - kloorheksidiin+lidokaiin - pressitud loseng - 5mg+1mg 36tk

Eesti - eesti - Ravimiamet

boehringer ingelheim vetmedica gmbh - lawsonia intracellularis, elus - suukaudse suspensiooni pulber ja lahusti - 1annus 50annus 1tk